Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Sutezolid

Generic Name: Sutezolid

Drug Type: Small Molecule

Chemical Formula: C_₁₆H_₂₀FN_₃O_₃S

CAS Number: 168828-58-8

Unique Ingredient Identifier: 3A71182L8P

Overview

Sutezolid has been used in trials studying the treatment of Tuberculosis.

Background

Sutezolid has been used in trials studying the treatment of Tuberculosis.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

Phase 2

Suspended

Posted: 2024/01/05

Sponsor:National Institute o...

ID:NCT06192160

A Pan-TB Regimen Targeting Host and Microbe

Phase 2

Recruiting

Posted: 2023/01/17

Sponsor:

The Aurum Institute ...

ID:NCT05686356

PanACEA Sutezolid Dose-finding and Combination Evaluation

Phase 2

Completed

Posted: 2019/05/22

Sponsor:

Michael Hoelscher

ID:NCT03959566

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid

Phase 1

Completed

Posted: 2017/06/26

Sponsor:Global Alliance for ...

ID:NCT03199313

PNU-100480 In Newly Diagnosed, Drug Sensitive Patients With Pulmonary TB; Early Bactericidal Activity; Whole Blood Assay

Phase 2

Completed

Posted: 2010/10/21

Sponsor:Sequella, Inc.

ID:NCT01225640

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy